High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
05 2019
Historique:
received: 15 06 2018
accepted: 20 11 2018
entrez: 24 4 2019
pubmed: 24 4 2019
medline: 23 1 2020
Statut: ppublish

Résumé

To investigate the prevalence and causes of diabetes in patients with primary aldosteronism (PA) in a multi-institutional cohort study in Japan. The prevalence of diabetes was determined in 2,210 patients with PA (diagnosed or glycated hemoglobin [HbA Of the 2,210 patients with PA, 477 (21.6%) had diabetes. This prevalence is higher than that in the general population (12.1%) or in 10-year cohorts aged 30-69 years. Logistic regression or χ Individuals with PA have a high prevalence of diabetes, which is associated mainly with SH. The prevalence of prediabetes is greater for bilateral than unilateral PA, suggesting a unique metabolic cause of bilateral PA.

Identifiants

pubmed: 31010944
pii: dc18-1293
doi: 10.2337/dc18-1293
doi:

Substances chimiques

Glycated Hemoglobin A 0
Aldosterone 4964P6T9RB

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

938-945

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Yuko Akehi (Y)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.

Toshihiko Yanase (T)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan tyanase@fukuoka-u.ac.jp.

Ryoko Motonaga (R)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Hironobu Umakoshi (H)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Mika Tsuiki (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Yoshiyu Takeda (Y)

Department of Internal Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

Takashi Yoneda (T)

Department of Internal Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

Isao Kurihara (I)

Department of Endocrinology, Metabolism, and Nephrology, School of Medicine, Keio University, Tokyo, Japan.

Hiroshi Itoh (H)

Department of Endocrinology, Metabolism, and Nephrology, School of Medicine, Keio University, Tokyo, Japan.

Takuyuki Katabami (T)

Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.

Takamasa Ichijo (T)

Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.

Norio Wada (N)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.

Yui Shibayama (Y)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.

Takanobu Yoshimoto (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan.

Kenji Ashida (K)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Yoshihiro Ogawa (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Masakatsu Sone (M)

Department of Diabetes, Endocrinology, and Nutrition, Kyoto University, Kyoto, Japan.

Nobuya Inagaki (N)

Department of Diabetes, Endocrinology, and Nutrition, Kyoto University, Kyoto, Japan.

Katsutoshi Takahashi (K)

Division of Metabolism, Showa General Hospital, Tokyo, Japan.
Department of Nephrology and Endocrinology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Megumi Fujita (M)

Department of Nephrology and Endocrinology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Minemori Watanabe (M)

Department of Endocrinology and Diabetes, Okazaki City Hospital, Okazaki, Japan.

Yuichi Matsuda (Y)

Department of Cardiology, Sanda City Hospital, Sanda, Japan.

Hiroki Kobayashi (H)

Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan.

Hirotaka Shibata (H)

Department of Endocrinology, Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan.

Kohei Kamemura (K)

Department of Cardiology, Shinko Hospital, Kobe, Japan.

Michio Otsuki (M)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Yuichi Fujii (Y)

Department of Cardiology, JR Hiroshima Hospital, Hiroshima, Japan.

Koichi Yamamoto (K)

Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Atsushi Ogo (A)

Clinical Research Institute, National Hospital Organization Kyusyu Medical Center, Fukuoka, Japan.

Shintaro Okamura (S)

Department of Endocrinology, Tenri Yorozu Hospital, Tenri, Japan.

Shozo Miyauchi (S)

Department of Internal Medicine, Uwajima City Hospital, Uwajima, Japan.

Tomikazu Fukuoka (T)

Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan.

Shoichiro Izawa (S)

Department of Endocrinology and Metabolism, Tottori University Hospital, Tottori, Japan.

Shigeatsu Hashimoto (S)

Division of Nephrology, Hypertension, Endocrinology, and Diabetology/Metabolism, Fukushima Medical University Hospital, Fukushima, Japan.

Masanobu Yamada (M)

Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.

Yuichiro Yoshikawa (Y)

Department of Endocrinology and Diabetes Mellitus, Misato Kenwa Hospital, Misato, Japan.

Tatsuya Kai (T)

Department of Cardiology, Saiseikai Tondabayashi Hospital, Tondabayashi, Japan.

Tomoko Suzuki (T)

Department of Public Health, School of Medicine, International University of Health and Welfare, Narita, Japan.

Takashi Kawamura (T)

Kyoto University Health Service, Kyoto, Japan.

Mitsuhide Naruse (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH